DeVry's College Gets ACCJC Renewal
DeVry Inc.(DV) recently announced that the Accrediting Commission for Community and Junior Colleges (:ACCJC), a regional accrediting commission, has renewed the accreditation for its Carrington College California for the next six years.
The ACCJC reaffirmed that the college has met all the standards and requirements for the accreditation. The renewal ensures that employers and other higher education institutions and governmental entities will give due recognition to the degrees and credits earned by students.
DeVry’s Carrington College, which operates through seven campuses, specializes in healthcare programs. At its fiscal third-quarter conference call, DeVry management announced its plans to focus more on core healthcare programs at the Carrington Colleges (includes Carrington College and Carrington College California) instead of emphasizing on some local markets where demand has been the weakest.
Healthcare has, of late, become a highly sought-after field of education. DeVry’s medical institutions like DeVry Brasil, Chamberlain College of Nursing and Carrington Colleges are doing well gaining from the higher demand for medical doctors and veterinarians. Enrollment rate at these colleges is also improving due to higher quality enquiries and conversion rates, resulting from improved recruitment efforts and new branding initiatives by DeVry.
In early July, DeVry acquired Brazilian healthcare education company, Faculdade Differential Integral (Facid), which offers primarily healthcare degrees including a Doctor of Medicine (M.D.) program. This acquisition is being considered as another effort to boost DeVry’s presence in health care education.
DeVry carries a Zacks Rank #4 (Sell). Other education companies worth a look are New Oriental Education & Technology Group (EDU), ATA, Inc. (ATAI) and K12, Inc. (LRN), all carrying a Zacks Rank #1 (Strong Buy).
Read the Full Research Report on DV
Read the Full Research Report on ATAI
Read the Full Research Report on EDU
Read the Full Research Report on LRN
More From Zacks.com
